indomethacin and ibotenic acid

indomethacin has been researched along with ibotenic acid in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Favrais, G; Gressens, P; Lelièvre, V; Schwendimann, L1
Catteau, J; Hennebert, C; Hennebert, O; Laudenbach, V; Legros, H; Leroux, P; Marret, S1

Other Studies

3 other study(ies) available for indomethacin and ibotenic acid

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Cyclooxygenase-2 mediates the sensitizing effects of systemic IL-1-beta on excitotoxic brain lesions in newborn mice.
    Neurobiology of disease, 2007, Volume: 25, Issue:3

    Topics: Animals; Animals, Newborn; Brain; Cerebral Palsy; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Drug Interactions; Excitatory Amino Acid Agonists; Female; Gene Expression Regulation, Enzymologic; Ibotenic Acid; Indomethacin; Interleukin-1beta; Mice; Neurotoxins; Pregnancy; Risk Factors; Sulfonamides

2007
Neuroprotective effects vary across nonsteroidal antiinflammatory drugs in a mouse model of developing excitotoxic brain injury.
    Neuroscience, 2010, May-19, Volume: 167, Issue:3

    Topics: Acetaminophen; Adrenal Cortex Hormones; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Betamethasone; Brain; Brain Damage, Chronic; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Encephalitis; Female; Ibotenic Acid; Indomethacin; Mice; Nerve Fibers, Myelinated; Neuroprotective Agents; Neurotoxins; Pregnancy; Pregnancy Complications; Treatment Outcome

2010